Evfraxy

denosumab · Biosimilar Collaborations Ireland Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Evfraxy, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: EMA Authorised: Evfraxy (denosumab) — Biosimilar Collaborations Ireland Limited